Hypogonadism: all 352 studies
Page 3 of 4. Open to participants first (44), then studies with results posted, then the rest; newest registration first within each.
- Study to Compare DITEST to Testosterone Undecanoate in Adult Men With HypogonadismCompletedNCT02966652Phase 1
- Human Menopausal Gonadotropin Combining With Human Chorionic Gonadotropin Treat Congenital Hypogonadotropic HypogonadismStatus unknownNCT02880280Phase 4
- Pubertal Induction in Individuals With HypogonadismStatus unknownNCT02871986
- Effects of Replacement Therapy With Sexual Steroid Hormones on the Insulin Sensitivity of Hypogonadal ManCompletedNCT02847806Phase 3
- Association Between Testosterone Levels and COPD SeverityStatus unknownNCT02824809
- Effect of Testosterone Replacement on Exercise Capacity in Hypogonadal Men After a Recent Myocardial InfarctionWithdrawnNCT02803073Phase 2/3
- Cardiovascular Outcomes of Low TestosteroneCompletedNCT02758431Not applicable
- Evaluation of Furosap in Human VolunteersCompletedNCT02748005Not applicable
- Effects of Gonadotropin Replacement Therapy on Metabolic Parameters in Patients With HypogonadismCompletedNCT02728440
- Autonomic Manifestations of Testosterone Deficiency in MenWithdrawnNCT02715713
- Testosterone Replacement in Renal FailureTerminatedNCT02712944Phase 1
- Efficacy of Pulsatile GnRH Therapy on Male Patients With Pituitary Stalk Interruption SyndromeStatus unknownNCT02705014Not applicable
- The Efficacy Study of FUROSAP: A Testosterone Booster Supplement In Humans.CompletedNCT02702882Not applicable
- Effects of Interleukin-1 Beta on Low Testosterone Levels in Men With Obesity and Metabolic SyndromeCompletedNCT02672592Phase 3
- Study of the Prevalence and Associated Factors With Hypogonadism in HIV + MenCompletedNCT02665559
- Testosterone, Metformin, or Both, for Hypogonadism in Obese MalesCompletedNCT02514629Phase 3
- Hormonal Predictors of Oncologic SurgeryCompletedNCT02471157
- Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal MenStatus unknownNCT02443090Phase 2
- Development and Validation of in Vitro Cell-based Bioassays for Nuclear Receptor ActivationCompletedNCT02434562
- Testosterone Therapy in Hypogonadal Men Treated With OpioidsCompletedNCT02433730Phase 4
- Effects of Transdermal Testosterone and/or Monthly Vitamin D on Fall Risk in Pre--frail Hypogonadal SeniorsTerminatedNCT02419105Phase 3
- Clomiphene Citrate for the Treatment of Obesity Related Male HypogonadismCompletedNCT02380755Phase 2
- TRT on BPH Hypoganadal MetS Patients. Florence-PROTESTCompletedNCT02366975Phase 4
- Psychological Outcomes in Isolated GnRH DeficiencyTerminatedNCT02356172
- Efficacy and Safety of Pulsatile Gonadotropin Releasing Hormone Pump Treatment in Patients With Idiopathic Hypogonadotropic HypogonadismStatus unknownNCT02310074Phase 4
- An Open-Label, Single-Dose Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of Radiolabeled Androxal in Healthy Male Subjects After Oral AdministrationCompletedNCT02274181Phase 1
- Study of the Effect of Testosterone Treatment on Metabolic Parameters and Urinary Symptoms in Bariatric PatientsCompletedNCT02248467
- Symptoms and Clinical Signs of Hypogonadism in Testicular Cancer SurvivorsCompletedNCT02240966
- Endothelial Dysfunction, Inflammation and Insulin Resistance in Congenital Hypogonadism and Effect of Testosteron Replacement TherapyCompletedNCT02171390Phase 4
- ITT-5 Mechanisms of Spermatogenesis in ManWithdrawnNCT02147964Phase 2
- Comparison of Assisted Reproductive Technology (ART) Outcomes Between Two Protocols of Induction of Ovulation in Patients With Hypogonadotropic HypogonadismStatus unknownNCT02140515Phase 4
- Assessing the Efficacy of Clomiphene Citrate in Patients With Azoospermia and HypoandrogenismWithdrawnNCT02137265Not applicable
- The Effect of Testosteron Replacement Treatment on the Fibroblast Growth Factor-23, Asymmetric Dimethylarginine and Vitamin D Levels in the Congenital Hypogonadotropic HypogonadismCompletedNCT02111473Phase 4
- Visceral Adiposity Index and Triglyceride/High-density Lipoprotein Cholesterol Ratio in the Congenital Hypogonadotropic Hypogonadism and Effect of Testosteron TreatmentCompletedNCT02111434Phase 4
- Bioequivalence Study of Test and Reference Testosterone Topical Gel, 1.62% Metered Pump in Testosterone Deficient Adult Male Subjects Under Fasting ConditionsCompletedNCT02110368Phase 3
- MRI Substudy; Metabolic Changes Due to Iatrogenic HypogonadismCompletedNCT02102646Phase 4
- An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal MenWithdrawnNCT02082197Phase 3
- Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or HypogonadismCompletedNCT02081300Phase 3
- Bone Mineral Markers in HypogonadismCompletedNCT02062307
- The Effects of Gonadotropin Replacement Therapy in Patients With HypogonadismCompletedNCT02042638
- A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62%CompletedNCT01993225Phase 3
- A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62%CompletedNCT01993212Phase 3
- Metabolomics During Testosterone TherapyCompletedNCT01963390
- Neuropeptides in Human ReproductionCompletedNCT01952782Phase 1
- Androgen Regulation of Priapism in Sickle Cell DiseaseWithdrawnNCT01940718Early Phase 1
- Evaluation of the Pharmacokinetics and Safety of Androxal in Male Subjects With Impaired Hepatic FunctionCompletedNCT01923870Phase 1
- Evaluation of Pharmacokinetic and Safety Profile of Androxal in Male Subjects With Impaired Renal FunctionCompletedNCT01923857Phase 1
- Testosterone Replacement in Non-alcoholic Steatohepatitis (TEREPINS)CompletedNCT01919294Phase 2
- Health Needs of Patients With Kallmann SyndromeCompletedNCT01914172
- Clomid in Men With Low Testosterone With and Without Prior TreatmentCompletedNCT01904734Phase 2
- Testogel® (Testosterone Gel 50mg/5g) in the Treatment of Male HypogonadismStatus unknownNCT01786473Phase 3
- Plasma RBP Levels in Patients With Idiopathic Hypogonadotrophic HypogonadismCompletedNCT01758094
- Testosterone Undecanoate and Quality of Life of Men and SpousesStatus unknownNCT01758029
- Vitamin D Treatment and Hypogonadism in MenCompletedNCT01748370Phase 4
- An Extension Study of Enclomiphene Citrate in the Treatment of Men With Secondary HypogonadismCompletedNCT01739582Phase 3
- Epigenetics and Metabolic Disorders in Men With the Klinefelter SyndromeCompletedNCT01703676
- Testosterone and Pain SensitivityWithdrawnNCT01689896Phase 4
- Clinical Outcomes in WHO Type I Anovulatory Women Using r-hFSH+r-hLH in a 2:1 Ratio or hMG-HPCompletedNCT01623570Not applicable
- Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary HypogonadismCompletedNCT01619683Phase 3
- Effects of Medications in Patients With HypogonadismCompletedNCT01601327Phase 4
- Testosterone Therapy of Men With Type 2 Diabetes Mellitus (T2DM)CompletedNCT01560546Phase 4
- The Effect of Testosterone Replacement on Endothelial Dysfunction, Inflammation and Insulin Resistance in Male Hypogonadotrophic HypogonadismCompletedNCT01533129Phase 4
- Hormonal Regulation of Puberty and FertilityCompletedNCT01511588
- The Effect of Testosterone Replacement on the High Density Lipoprotein Cholesterol SubgroupsCompletedNCT01454011Phase 4
- Elucidating Kisspeptin Physiology by Blocking Kisspeptin SignalingCompletedNCT01438073Phase 1
- Kisspeptin in the Evaluation of Delayed PubertyCompletedNCT01438034Phase 1
- Sequential Therapy for Hypogonadotropic HypogonadismCompletedNCT01403532Phase 4
- A One Year Open Label Study for the Treatment of Hypogonadism (Low Testosterone) in Men Who Have Completed ZA-203CompletedNCT01386567Phase 2
- Testosterone Therapy in Heart FailureWithdrawnNCT01377103Not applicable
- Androgen for Leydig Cell ProliferationCompletedNCT01206270Phase 2/3
- A Study to Evaluate the Potential for Interpersonal Transfer of Testosterone Following Single Dose ApplicationCompletedNCT01172366
- Detailed Clinical, Biochemical and Genetic Characterization in Gonadotropin-releasing Hormone (GnRH) Deficiency DisordersTerminatedNCT01165619
- Metabolic Syndrome Criteria and the Effect of Testosterone Treatment in Young Men With HypogonadismCompletedNCT01160341Phase 4
- Quality of Life With TESTIM®CompletedNCT01148433
- Pharmacokinetic and Comparative Bioavailability Study of Testosterone Absorption After Administration of Testosterone Gel 1.62% to the Upper Arms/Shoulders Using an Application Site Rotation or a Combination of Application Sites in Hypogonadal MalesCompletedNCT01133548Phase 1
- Testosterone Replacement in Metabolic Syndrome and InflammationCompletedNCT01123278Phase 4
- Testosterone Replacement Therapy Decreases Plasma Paraoxonase 1 Enzyme Activity In Male Patients With HypogonadismCompletedNCT01107067Phase 4
- NEBIDO in Symptomatic Late Onset Hypogonadism (SLOH)TerminatedNCT01092858Phase 4
- Effect of Testosterone on Endothelial Function and Microcirculation in Type 2 Diabetic Patients With HypogonadismTerminatedNCT01084369Phase 4
- Study to Evaluate the Safety and Efficacy of Androxal Treatment in Men With Secondary HypogonadismCompletedNCT01067365Phase 3
- Efficacy and Safety of Fispemifene in the Treatment of Hypogonadal Men With Chronic Obstructive Pulmonary Disease That Are on Oral Glucocorticoid TherapyCompletedNCT01061970Phase 2
- Study of Serum Testosterone Levels in Non-dosed Females After Secondary ExposureCompletedNCT00998933Phase 1
- Study to Evaluate the Safety and Efficacy of Androxal™ Treatment in Men With Secondary HypogonadismCompletedNCT00962637Phase 3
- Kisspeptin Administration in the AdultCompletedNCT00914823Phase 1
- Registry of Hypogonadism in MenCompletedNCT00858650
- To Determine the Effects of Deodorant, Antiperspirant and Washing on the Pharmacokinetics of 2% Testosterone MD LotionCompletedNCT00857168Phase 1
- Efficacy and Tolerability of Testogel/Nebido in Combination With Exercise and Diet in Hypogonadal Male PatientsCompletedNCT00847314
- Efficacy of Nebido on Bone Mineral Density (BMD) in Hypogonadal Paraplegic Patients With Confirmed OsteoporosisCompletedNCT00838838
- Efficacy Study for Use of Dutasteride (Avodart) With Testosterone ReplacementCompletedNCT00752869Phase 4
- Androgen Deprivation Therapy StudyTerminatedNCT00743327
- Nebido Versus Placebo in Elderly Men With Typical Symptoms of Late Onset Hypogonadism Over a Period of 54 WeeksWithdrawnNCT00710827Phase 4
- Influence of Administration Route of Testosterone on Male FertilityWithdrawnNCT00705796Phase 1
- Odense Androgen Study - The Effect of Testim and Training in Hypogonadal MenStatus unknownNCT00700024Phase 4
- Clomiphene in Males With Prolactinomas and Persistent HypogonadismCompletedNCT00697814Phase 2
- The Effect of IM Testosterone Undecanoate on Biochemical and Anthropometric Characteristics of Metabolic Syndrome in Hypogonadal MenStatus unknownNCT00696748Phase 3
- NASOBOL in Hypogonadal Men in Comparison to Testosterone Levels in Normal Healthy Male VolunteersCompletedNCT00647868Phase 1
- Follow-up of Serum Androgen Profile After Bariatric Surgery in Men With Obesity Related Hypogonadotropic HypogonadismCompletedNCT00624624
- Reandron in Diabetic Men Witn Low Testosterone LevelCompletedNCT00613782Phase 2/3
- Testosterone and Lipolysis, Insulin Sensitivity and Protein MetabolismCompletedNCT00613288Not applicable
- Study of 3 Doses of ARD-0403 in Testosterone Deficient MenCompletedNCT00597051Phase 2